Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of bioactive molecules with improved metabolic stability and binding affinity. Its nitrile and hydroxyl functional groups allow for further chemical modifications, making it valuable in medicinal chemistry for constructing complex drug candidates. Commonly employed in the preparation of enzyme inhibitors and receptor modulators, especially in research targeting central nervous system disorders and inflammatory diseases. The difluoroethyl moiety enhances membrane permeability and pharmacokinetic properties, which is advantageous in optimizing lead compounds during drug discovery.